Filing Details
- Accession Number:
- 0001601485-22-000044
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-05-27 16:19:36
- Reporting Period:
- 2021-02-09
- Accepted Time:
- 2022-05-27 16:19:36
- Original Submission Date:
- 2021-02-11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1601485 | Angion Biomedica Corp. | ANGN | () | 4/A |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1199070 | F Victor Ganzi | C/O Angion Biomedica Corp. 51 Charles Lindbergh Blvd. Uniondale NY 11553 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-02-09 | 614,310 | $6.43 | 1,069,837 | No | 4 | X | Direct | |
Common Stock | Disposition | 2021-02-09 | 246,720 | $16.00 | 823,117 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | X | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant to Purchase Common Stock | Disposition | 2021-02-09 | 614,310 | $0.00 | 614,310 | $6.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2028-07-05 | No | 4 | X | Direct |
Footnotes
- On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person.